NASDAQ:TGAN - Nasdaq - US89386L1008 - Common Stock - Currency: USD
5.1
+0.34 (+7.14%)
The current stock price of TGAN is 5.1 USD. In the past month the price increased by 4.08%. In the past year, price increased by 48.26%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
NVDA | NVIDIA CORP | 51.31 | 3292.19B | ||
TSM | TAIWAN SEMICONDUCTOR-SP ADR | N/A | 1028.18B | ||
AVGO | BROADCOM INC | 44.99 | 1024.94B | ||
TXN | TEXAS INSTRUMENTS INC | 38.92 | 184.02B | ||
QCOM | QUALCOMM INC | 15.22 | 182.97B | ||
AMD | ADVANCED MICRO DEVICES | 33.39 | 179.61B | ||
ARM | ARM HOLDINGS PLC-ADR | 99.89 | 152.23B | ||
ADI | ANALOG DEVICES INC | 38.04 | 118.53B | ||
MU | MICRON TECHNOLOGY INC | 24.65 | 110.12B | ||
INTC | INTEL CORP | 49.74 | 107.69B | ||
MRVL | MARVELL TECHNOLOGY INC | 72.59 | 89.83B | ||
NXPI | NXP SEMICONDUCTORS NV | 18.1 | 60.11B |
Transphorm, Inc. is a semiconductor company, which engages in the development of wide-bandgap gallium nitride (GaN) power electronic products. The company is headquartered in Goleta, California and currently employs 126 full-time employees. The company went IPO on 2020-07-27. The firm develops gallium nitride (GaN) products for high-voltage power conversion applications. The firm's Gen IV platform delivers benefits both in assembly and applications, which is the catalyst for the SuperGaN brand. The firm's GaN technology benefits various markets. The highest adoption rates are projected for the various application areas, including power supplies in infrastructure and information technology (IT); adapters, gaming power supplies in consumer and computing; battery chargers, uninterruptible power supply (UPS) in broad industry; electric vehicles, charging in automotive; and mobile adapters, radio frequency (RF) material in fifth generation (5G). Its GaN solutions support a range of power levels across the range of applications. Its device portfolio includes 650 V and 900 V FETs, with 1200 V FETs in development.
TRANSPHORM INC
75 Castilian Drive
Goleta CALIFORNIA US
Employees: 126
Company Website: https://www.transphormusa.com/
Phone: 18054561300
The current stock price of TGAN is 5.1 USD. The price increased by 7.14% in the last trading session.
The exchange symbol of TRANSPHORM INC is TGAN and it is listed on the Nasdaq exchange.
TGAN stock is listed on the Nasdaq exchange.
9 analysts have analysed TGAN and the average price target is 5.66 USD. This implies a price increase of 11% is expected in the next year compared to the current price of 5.1. Check the TRANSPHORM INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
TRANSPHORM INC (TGAN) has a market capitalization of 323.14M USD. This makes TGAN a Small Cap stock.
TRANSPHORM INC (TGAN) currently has 126 employees.
TRANSPHORM INC (TGAN) has a support level at 4.9. Check the full technical report for a detailed analysis of TGAN support and resistance levels.
The Revenue of TRANSPHORM INC (TGAN) is expected to grow by 37.91% in the next year. Check the estimates tab for more information on the TGAN EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
TGAN does not pay a dividend.
TRANSPHORM INC (TGAN) will report earnings on 2024-08-12, after the market close.
TRANSPHORM INC (TGAN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.44).
ChartMill assigns a technical rating of 7 / 10 to TGAN. When comparing the yearly performance of all stocks, TGAN is one of the better performing stocks in the market, outperforming 90.99% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to TGAN. TGAN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months TGAN reported a non-GAAP Earnings per Share(EPS) of -0.44. The EPS decreased by -7.32% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -127.67% | ||
ROE | -228.5% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 78% to TGAN. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 24.61% and a revenue growth 37.91% for TGAN